We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Health Impact Study of Aquatabs in Tamale, Ghana

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00252928
Recruitment Status : Completed
First Posted : November 15, 2005
Last Update Posted : October 30, 2007
Information provided by:

Study Description
Brief Summary:
The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.

Condition or disease Intervention/treatment
Diarrhea Other: Sodium dichloroisocyanurate (NaDCC) tablets Other: Placebo

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 240 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Prevention
Official Title: Health Impact Study of a Water Treatment Tablet, Aquatabs, in Tamale, Ghana
Study Start Date : July 2006
Study Completion Date : November 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Placebo Comparator: A
Placebo group does not receive Aquatabs.
Other: Placebo
Experimental: B
Intervention arms receives Aquatabs.
Other: Sodium dichloroisocyanurate (NaDCC) tablets
Intervention arm receives NaDCC tablets to use for to disinfect their household water for use for 20L of water. Ideally, disinfection occurs every day.
Other Name: Aquatabs

Outcome Measures

Primary Outcome Measures :
  1. Measure the impact of Aquatabs on diarrhea among persons in households in Tamale, Ghana. [ Time Frame: 12 weeks ]

Secondary Outcome Measures :
  1. Assess the microbiological quality of household water among persons living in Tamale, Ghana. [ Time Frame: 12 weeks ]
  2. Determine the acceptability of Aquatabs. [ Time Frame: 12 weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Households with at least one child under 5 years old

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00252928

United States, Georgia
Emory University Center for Global Safe Water
Atlanta, Georgia, United States, 30322
Tamale, Ghana
University of Development Studies
Tamale, Ghana
Sponsors and Collaborators
Centers for Disease Control and Prevention
Emory University Center for Global Safe Water
University for Development Studies, Tamale, Ghana
Principal Investigator: Seema Jain, MD Centers for Disease Control and Prevention
Principal Investigator: Robert Quick, MD Centers for Disease Control and Prevention
More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00252928     History of Changes
Other Study ID Numbers: CDC-NCID-4730
First Posted: November 15, 2005    Key Record Dates
Last Update Posted: October 30, 2007
Last Verified: October 2007

Keywords provided by Centers for Disease Control and Prevention:
sodium dichloroisocyanurate
water purification

Additional relevant MeSH terms:
Signs and Symptoms, Digestive
Signs and Symptoms
Antifungal Agents
Anti-Infective Agents
Antiviral Agents